Luye Pharma : Embracing a New Era of Globalization-- Congratulations on the 22nd Anniversary of Luye Group

June 18, 2016 was the 22nd birthday of Luye. At Jiaodong Theatre in Yantai, a city on the shore of the Yellow Sea where Luye was founded, the management teams and staff representatives of various business segments from China, Singapore, Australia, South Korea, and the U.S. gathered together to celebrate the 22nd anniversary of Luye Group. At the same time, the Luyers who couldn't attend onsite also sent their wishes via video from all over the world.

Luye has become a global group with businesses in multiple fields of healthcare industry, and over 10,000 employees across 45 countries and regions worldwideLuyers have been constantly marching towards the dream, and have together witnessed the growth of Luye Group.

Gold Leaf Medal

In the past 22 years, each milstone recorded the concerted efforts, loyalty, and perseverance of Luyers. This year, another 51employees have joined hands with Luye for ten years. With gratitude and respect, the Gold Leaf Medals awarded those employees for their companionship over the past ten years. Till June 18, 2016, a total of 1,118 Luyers have been awarded the Gold Leaf Medal.

Outstanding Contribution Award

From the beginning of 2016, the three business segments of Luye Group have all been making significant achievements. The business expansion and achievements are the outcome of our excellent team work, under the guidance of Luye's culture: Innovation Makes Excellence. This year the Outstanding Contribution Awards go to Luye Pharma's EU Certification project team, Luye Medical (China) team, the Healthe Care acquisition project team, and Vela Diagnostics team .
Development Plan for Each Business Segment of Luye Group

Looking forward, how will Luye develop sustainably after 2016? Each business segment shared their development plan respectively.

Ms. Sammy Jiang, Vice President of Luye Group, presented a 10-year strategic planning report. In the past 10 years, Luye Pharma has done an excellent job in meeting international standards in terms of research & development, innovation, and quality management. In the following 10 years, Luye Pharma will advance in both domestic and international markets, and grow mainly throughM&As. In the Chinese market, focus will be placed on four areas including central nervous system, oncology, cardiovascular diseases, and diabetes. In the international market, however, the highlight will be central nervous system and oncology. Luye Pharma's goal is to be one of the top 100 global pharmaceutical companies by 2020.

Luye Pharma (International) CEO Dr. Zhang Yehong introduced how to expand the overseas business for Luye Pharma. He pointed out that the first thing to consider is why go global. The well-developed markets such as the U.S., Europe, and Japan all possess excellent technologies, high-quality platforms, as well as outstanding talent management. International cooperation can help enhance the internal capabilities of Luye. Secondly, how to go global? In the fast-changing international environment, it is crucial to have the wit to find suitable opportunities. Meanwhile, as an outstanding person or organization, we must learn how to accomplish demanding tasks, and have the courage to take responsibilities.

Mr. Yang Rongbing, Executive Vice President of Luye Pharma, emphasized the development strategy of Luye Pharma and his understanding of globalization. Today's globalization is a combination of Chinese and Western advantages. To step into the future, Chinese enterprises need to offer more superior products and service to the Western markets. Meanwhile, Luyers must tackle the challenges in corporate culture, organizational capability, and talents on the new journey of globalization. Luyers need to continuesustainingthe current success, and steadily introduce high-quality talents, platforms, and technologies for better products, service, and solutions.

The management team representatives of Luye Medical from different countries vividly introduced the development status and future planning of the group through a panel discussion. Through the introduction of new technology, self-innovation and resource integration, Luye Medical has thus far established a network of global leading technology, operations, management and service. The internationalized medical team will continue to provide customers with high-qualitypatient-centric medical service.

Luye Investment has also accomplished remarkable developments in the areas of biological medicine and precision medicine. Vela Diagnostics, a Singapore-based provider of genetic diagnostic technology, has expanded its global footprint in Asia, Europe and America. Vela Diagnostics COO Dr. Huang Wen introduced the cutting-edge technology of precision medicine and individualized treatment.

In addition, Luye Investment has also made progress in developing fully human monoclonal antibody biological medicine technology and established an advanced antibody technology platform with a unique value. The layout and achievements of Luye Investment in the field of total health industry position Luye Group strategically to become a provider of 'total healthcare solutions' in the future.

Address from Chairman Liu

On behalf of the Board of Directors of Luye Group, Chairman Liu Dianbo extended his heartfelt gratitude to over 10,000 Luye employees worldwide and their family members, to clients who stay side by side with Luye over the course of its growth, and to friends from all walks of life for their consistent support. In particular, Chairman Liu thanked the original founders for their perseverance and those employees who have been working at Luye Group for more than ten years.

Chairman Liu reviewed the track of thought of Luye Pharma, Luye Medical, and Luye Investment, summarized the development of Luye Group over the past two decades, and shared the new pattern and new future of the Group, as well as the new strategy of becoming a provider of total healthcare solutions. Once again, he emphasized Luye's mission of 'Professional Technology Serves Human Health' and vision 'To be the most respected globally leading enterprise in the healthcare industry'.

Every June 18th represents a new starting point for Luye Group. With equal emphasis on responsibility and honor, we are forging ahead on the road leading to our dreams. There is still a long way to go for an even brighter future. Let's join hands and make concerted efforts to build Luye Group into the most respected globally leading enterprise in the healthcare industry!